MGNX

SEC source: 0001125345-24-000106 · wk-form4_1716410028.xml · nonDerivative · entry 1

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000105 · wk-form4_1716410014.xml · derivative · entry 2

O'Brien Federica F. · CIK 0001140119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

SEC source: 0001125345-24-000105 · wk-form4_1716410014.xml · nonDerivative · entry 1

O'Brien Federica F. · CIK 0001140119 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000104 · wk-form4_1716409997.xml · derivative · entry 2

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

SEC source: 0001125345-24-000104 · wk-form4_1716409997.xml · nonDerivative · entry 1

Liu Margaret · CIK 0001324059 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000103 · wk-form4_1716409983.xml · derivative · entry 2

Chhabra Meenu · CIK 0001534200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

SEC source: 0001125345-24-000103 · wk-form4_1716409983.xml · nonDerivative · entry 1

Chhabra Meenu · CIK 0001534200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000101 · wk-form4_1716409937.xml · derivative · entry 2

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

SEC source: 0001125345-24-000101 · wk-form4_1716409937.xml · nonDerivative · entry 1

HURWITZ EDWARD · CIK 0001211840 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000102 · wk-form4_1716409951.xml · derivative · entry 2

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

F2 · derivative.exercise_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

F2 · derivative.expiration_date: The RSUs vested on May 20, 2024, which was one day prior to the Issuer's 2024 Annual Meeting of Stockholders held on May 21, 2024.

SEC source: 0001125345-24-000102 · wk-form4_1716409951.xml · nonDerivative · entry 1

Ferrante Karen Jean · CIK 0001598502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock unit (RSU) grant was approved by the Board of Directors on May 31, 2023. Each RSU represents a contingent right to receive one share of the Issuer Common Stock.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · derivative · entry 7

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,500

Underlying: Common Stock · 42,500 shares

Expires 2033-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F6 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the 2/15/2023 date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 6

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $18.00 to $18.84. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,165

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $17.05 to $17.99. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,516

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.01 to $16.58. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,748

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.07 to $15.94. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/8/2023.

SEC source: 0001125345-24-000079 · wk-form4_1712614042.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · derivative · entry 5

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,375

Underlying: Common Stock · 8,750 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · derivative · entry 4

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,875 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000063 · wk-form4_1709932476.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000056 · wk-form4_1709760021.xml · derivative · entry 4

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,000

Underlying: Common Stock · 15,000 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000056 · wk-form4_1709760021.xml · nonDerivative · entry 3

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,900

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.50 to $19.78. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000056 · wk-form4_1709760021.xml · nonDerivative · entry 2

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,059

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/21/2022.

SEC source: 0001125345-24-000056 · wk-form4_1709760021.xml · nonDerivative · entry 1

Risser Eric Blasius · CIK 0001587774 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000055 · wk-form4_1709759960.xml · derivative · entry 3

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Stock · 10,000 shares

Expires 2030-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

SEC source: 0001125345-24-000055 · wk-form4_1709759960.xml · nonDerivative · entry 2

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,316

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/17/2023.

SEC source: 0001125345-24-000055 · wk-form4_1709759960.xml · nonDerivative · entry 1

Spitznagel Thomas · CIK 0001675464 · Sr VP, Technical Ops

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001125345-24-000054 · wk-form4_1709759899.xml · nonDerivative · entry 1

Karrels James · CIK 0001587477 · SVP, CFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,452

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/7/2022.

F2 · ownership.direct: Owned jointly with reporting person's wife.

SEC source: 0001125345-24-000049 · wk-form4_1709155207.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.57 to $18.37. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,019

SEC source: 0001125345-24-000047 · wk-form4_1708982859.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · derivative · entry 3

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · nonDerivative · entry 2

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,892

SEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · nonDerivative · entry 1

Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000043 · wk-form4_1708472493.xml · derivative · entry 3

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,330

Underlying: Common Stock · 16,670 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000043 · wk-form4_1708472493.xml · nonDerivative · entry 2

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,798

SEC source: 0001125345-24-000043 · wk-form4_1708472493.xml · nonDerivative · entry 1

Eck Stephen L. · CIK 0001669041 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · derivative · entry 3

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,664

Underlying: Common Stock · 13,336 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · nonDerivative · entry 2

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,895

SEC source: 0001125345-24-000041 · wk-form4_1708470299.xml · nonDerivative · entry 1

Peters Jeffrey Stuart · CIK 0001706903 · Senior VP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000040 · wk-form4_1708470288.xml · derivative · entry 3

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,659

Underlying: Common Stock · 42,341 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000040 · wk-form4_1708470288.xml · nonDerivative · entry 2

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,077,628

SEC source: 0001125345-24-000040 · wk-form4_1708470288.xml · nonDerivative · entry 1

Koenig Scott · CIK 0001587514 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,091,977

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 127,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · derivative · entry 3

Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,332

Underlying: Common Stock · 6,668 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

SEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · nonDerivative · entry 2

Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,213

SEC source: 0001125345-24-000039 · wk-form4_1708470273.xml · nonDerivative · entry 1

Cilinski Lynn · CIK 0001587150 · VP, Controller and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On February 15, 2023 the reporting person was granted 20,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.